These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18025036)

  • 21. miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.
    Lu Y; Hippen KL; Lemire AL; Gu J; Wang W; Ni X; Ranganathan P; Levine BL; Riley JL; June CH; Turka LA; Munn DH; Garzon R; Lu L; Blazar BR
    Blood; 2016 Sep; 128(10):1424-35. PubMed ID: 27485827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of a microRNA expression vector for function analysis of microRNA.
    Furukawa N; Sakurai F; Katayama K; Seki N; Kawabata K; Mizuguchi H
    J Control Release; 2011 Feb; 150(1):94-101. PubMed ID: 21146569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEI-complexed LNA antiseeds as miRNA inhibitors.
    Thomas M; Lange-Grünweller K; Dayyoub E; Bakowsky U; Weirauch U; Aigner A; Hartmann RK; Grünweller A
    RNA Biol; 2012 Aug; 9(8):1088-98. PubMed ID: 22894918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity, duplex degradation and subcellular localization of antagomirs.
    Krützfeldt J; Kuwajima S; Braich R; Rajeev KG; Pena J; Tuschl T; Manoharan M; Stoffel M
    Nucleic Acids Res; 2007; 35(9):2885-92. PubMed ID: 17439965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN.
    Yuan J; Su Z; Gu W; Shen X; Zhao Q; Shi L; Jin C; Wang X; Cong H; Ju S
    Cancer Biomark; 2019; 24(3):279-289. PubMed ID: 30883341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
    Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
    BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of different chemically modified inhibitors of miR-199b in vivo.
    Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
    Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
    Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
    Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
    Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
    Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
    Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
    J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-leukemia mechanism of miR-17 and miR-20a silencing mediated by miRNA sponge].
    Niu WY; Wu SQ; Xu ZZ; Lin J; Zhan R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):932-7. PubMed ID: 25130806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
    Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling.
    Zhang JF; Fu WM; He ML; Xie WD; Lv Q; Wan G; Li G; Wang H; Lu G; Hu X; Jiang S; Li JN; Lin MC; Zhang YO; Kung HF
    RNA Biol; 2011; 8(5):829-38. PubMed ID: 21743293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration.
    Li P; Sheng C; Huang L; Zhang H; Huang L; Cheng Z; Zhu Q
    Breast Cancer Res; 2014 Nov; 16(6):473. PubMed ID: 25394902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA
    Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A PCR-Based Method to Construct Lentiviral Vector Expressing Double Tough Decoy for miRNA Inhibition.
    Qiu H; Zhong J; Luo L; Liu N; Kang K; Qu J; Peng W; Gou D
    PLoS One; 2015; 10(12):e0143864. PubMed ID: 26624995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lentiviral vector bearing a reverse intron demonstrates superior expression of both proteins and microRNAs.
    Poling BC; Tsai K; Kang D; Ren L; Kennedy EM; Cullen BR
    RNA Biol; 2017 Nov; 14(11):1570-1579. PubMed ID: 28594311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity.
    Plank MW; Maltby S; Tay HL; Stewart J; Eyers F; Hansbro PM; Foster PS
    PLoS One; 2015; 10(12):e0144810. PubMed ID: 26693910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Illuminating miRNA Inhibition: Visualizing the Interaction between Anti-miRNA Oligonucleotide and Target miRNA Using FRET.
    Zhu H; Kamiya Y; Asanuma H
    ACS Chem Biol; 2023 Oct; 18(10):2281-2289. PubMed ID: 37789826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity.
    Li JJ; Tay HL; Maltby S; Xiang Y; Eyers F; Hatchwell L; Zhou H; Toop HD; Morris JC; Nair P; Mattes J; Foster PS; Yang M
    J Allergy Clin Immunol; 2015 Aug; 136(2):462-73. PubMed ID: 25772595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.